A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

Clinical trial NCT06929299 · RECRUITING

Trial details

NCT number: NCT06929299
Sponsor: Jiangsu BioJeTay Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Immune Thrombocytopenia (ITP)

Start date: 2025-05-12
Primary completion: 2026-09-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.